Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Sales, net	$ 33,683	$ 33,623
Cost of sales	28,800	28,122
Gross profit	4,883	5,501
Selling and administrative expenses	3,531	4,385
Operating income	1,352	1,116
Other income (expense), net:
Interest expense	(964)	(979)
Change in fair value of deriative instruments	(21)	(133)
Impairment charge on investment in iBio, Inc.	(152)	(139)
Other income (expense), net	5	245
Total other expense, net	(1,132)	(1,006)
Income before income taxes	220	110
Income tax expense, net	89	17
Net income	$ 131	$ 93
Basic net income per common share (in Dollars per share)	$ 0.01	$ 0.00
Diluted net income per common share (in Dollars per share)	$ 0.01	$ 0.00
Weighted average common shares outstanding - basic (in Shares)	21,081,955	21,080,174
Equivalent shares outstanding (in Shares)	111,863	163,456
Weighted average common shares outstanding - diluted (in Shares)	21,193,818	21,243,630